Now live: Pro — the full 13F research suite for serious investorsSee pricing →
22NW, LP

Q3 2023 · 13F-HR

22NW, LPholdings as filed

Filed 2023-11-14 · accession 0001214659-23-015144

$140.3M
Reported value
14
Positions
2023-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
859241101STRLSTERLING INFRASTRUCTURE INC$27.1M19.3%369,222CommonSOLE
350060109FSTRFOSTER L B CO$24.8M17.7%1,313,121CommonSOLE
L72967109OECORION S.A.$15.7M11.2%736,472CommonSOLE
034569103ANEBANEBULO PHARMACEUTICALS INC$15.5M11.0%5,066,290CommonSOLE
514766104LFCRLIFECORE BIOMEDICAL INC$13.3M9.44%1,755,161CommonSOLE
068463108BBSIBARRETT BUSINESS SVCS INC$9.0M6.41%99,686CommonSOLE
230215105CULPCULP INC$6.8M4.82%1,212,380CommonSOLE
19260Q957COINBASE GLOBAL INC$5.8M4.11%2,310PUTSOLE
563571405MTWMANITOWOC CO INC$5.4M3.82%356,115CommonSOLE
307675108FB1FARMER BROS CO$5.0M3.59%1,955,526CommonSOLE
71742W103PFXPHENIXFIN CORP$4.5M3.19%117,885CommonSOLE
53000N108LIANYLIANBIO$3.3M2.35%2,211,678CommonSOLE
86272A206SSKNEURSTRATA SKIN SCIENCES INC$3.2M2.28%5,369,954CommonSOLE
744375205PMDUSDPSYCHEMEDICS CORP$1.1M0.78%274,418CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.